Literature DB >> 22486

Demonstration and characterization of a serum factor produced by activated T cells.

M Dardenne, J F Bach.   

Abstract

Spleen rosette forming cells (RFC) from adult thymectomized mice have a low sensitivity to inhibition by anitheta serum (AOS) and azathioprine (AZ) in comparison with normal spleen or thymus RFC. Thymus extracts and normal mouse serum (but not spleen extracts or thymectomized mouse serum) correct this abnormality after a 30 min in vitro incubation with spleen cells. We report here the existence of a serum factor produced in allogeneic reactions with the same activity on rosettes as thymic factor (TF). This 'allogeneic' factor (AF) is detectable in mice undergoing a graft versus host reaction (GVHR), rejecting skin allografts or allogeneic cells or responding to thymus-dependent antigens such as heterologous red blood cells or BSA. The T-cell origin of AF is indicated by AF presence in nude mice submitted to the same allogeneic stimuli as listed above and in normal mice injected with PVP or LPS. AF is distinct from the thymic factor as shown by differences in electric charge. Moreover, in contrast with TF there is no specific high molecular weight inhibitor of AF. Preliminary biochemical studies indicate that AF is probably a peptide of low molecular weight (greater than 5000 daltons). Its target cell is probably a T-cell precursor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 22486      PMCID: PMC1445516     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human.

Authors:  J F Bach; M Dardenne; J M Pleau; M A Bach
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

2.  The allogeneic effect: increased cellular immune and inflammatory responses.

Authors:  G J Elfenbein; I Green; W E Paul
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

3.  Reconstitution of T cell-depleted spleen cell populations by factors derived from T cells. 3. Mechanism of action of T cell-derived factors.

Authors:  R M Gorczynski; R G Miller; R A Phillips
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

4.  In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes.

Authors:  K Komuro; E A Boyse
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

5.  Mode of action of a supernatant activity from T-cell cultures that nonspecifically stimulates the humoral immune response.

Authors:  P Hunter; J R Kettman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

6.  When allogeneic mouse spleen cells are mixed in vitro the T-cells secrete a product which guides the maturation of B-cells.

Authors:  S Britton
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

7.  [Demonstration of 2 low molecular weight factors, 1 secreted by the thymus gland, the other by activated T cells, conferring theta antigen to theta negative lymphocytes].

Authors:  J F Bach; M Dardenne; J M Pleau
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1974-01-07

8.  Carrier specificity and the allogeneic effect in mice.

Authors:  K Rajewsky; G E Roelants; B A Askonas
Journal:  Eur J Immunol       Date:  1972-12       Impact factor: 5.532

9.  Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes.

Authors:  R S Geha; E Schneeberger; F S Rosen; E Merler
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  The allogeneic effect in inbred mice. IV. Regulatory influences of graft-vs.-host reactions on host T lymphocyte functions.

Authors:  D P Osborne; D H Katz
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  1 in total

1.  Generation of a monoclonal antibody against facteur thymique serique (FTS).

Authors:  K Ohga; G S Incefy; C Y Wang; R A Good
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.